MERLO FEDERICO

Pagan, E., Sala, I., Pala, L., Natali, F., Merlo, F., Oriecuia, C., et al. (2025). Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer. JNCI CANCER SPECTRUM, 9(5) [10.1093/jncics/pkaf085]. Dettaglio

Pala, L., Merlo, F., Sala, I., Pagan, E., Oriecuia, C., Specchia, C., et al. (2025). Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 117(8), 1557-1564 [10.1093/jnci/djaf049]. Dettaglio

Conforti, F., Merlo, F., Pala, L., Canzian, J., Tinterri, B., De Pas, T., et al. (2025). Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence. JOURNAL OF CLINICAL ONCOLOGY, 43(30), 3237-3244 [10.1200/JCO-25-01148]. Dettaglio